Adverum Biotechnologies

World Rank (Jan-05-2024)

21,963

Market Cap (Jan-05-2024)

0.090 Billion USD

World Rank (Jul-30-2023)

17,827

Market Cap (Jul-30-2023)

0.209 Billion USD

World Rank (Jan-07-2022)

19,827

Market Cap (Jan-07-2022)

0.165 Billion USD

World Rank (Jan-01-2021)

7,717

Market Cap (Jan-01-2021)

1.057 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

ADVM

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

0 Million USD

Annual Net Income in USD

-118 Million USD

Annual Results for Period Ending

Dec-2020 ending year

Balance Sheet for Period Ending

Dec-2020 ending year

Business Sector

Company Website

ADVERUM BIOTECHNOLOGIES

Wikipedia

Yahoo

Yahoo @ Nasdaq

Company Profile

Adverum Biotechnologies is a Clinical Stage Gene Therapy company targeting unmet medical need in ocular and rare diseases. It is a core capabilities include clinical development, novel vector discovery and i in house manufacturing expertise, specifically in scalable process development, assay development and current good manufacturing practices (cGMP) quality control. The headquarters is in USA.

Founded Year

2006

IPO Year

2014

Stock Exchange

Nasdaq

Nasdaq Sector

Health Care

Nasdaq Industry

Biotechnology: Biological Products (No Diagnostic Substances)